Executive Summary
DOE's NNSA non-competitively awarded General Atomics $91.4M for inertial confinement fusion (ICF) targets R&D, with base + options at $547.2M through 2029 and potential to 2035, signaling bullish revenue visibility via cost-plus-fixed-fee structure. $43.6M outlays to date and $1.8M subawards indicate front-loaded progress with low execution risk for this established non-small business.
Key upside lies in $455.8M unobligated options amid NNSA's experimental sciences focus.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior DOE Energy Grants digest from March 06, 2026.
Investment Signals (1)
- Major NNSA ICF R&D Revenue Commitment (HIGH)▲
Non-competitive $91.4M obligation with $547.2M total potential provides sustained revenue through 2029+ for General Atomics in applied science R&D.
Risk Flags (1)
- Execution [MEDIUM RISK]▼
Options exercise uncertainty and front-loaded $43.6M outlays may lead to variable future disbursements; minor subaward dependencies at $1.8M.
Opportunities (1)
- ◆
$455.8M unobligated options plus potential 2035 extension in NNSA NA-113 experimental sciences.
Sector Themes (1)
- ◆
Sole award underscores DOE's commitment to non-competitive funding for established players in inertial confinement fusion under NAICS 541715.
Watch List (1)
- 👁
{"entity"=>"General Atomics", "reason"=>"Dominates this $547M NNSA ICF program with execution milestones ahead", "trigger"=>"Options funding announcements or outlay acceleration beyond $43.6M"}
Get daily alerts with 1 investment signals, 1 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: DOE Energy Grants
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
US Merger & Acquisition SEC Filings — May 27, 2026
US Merger & Acquisition SEC Filings
May 26, 2026
US Pre-Market SEC Filings Roundup — May 26, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
Biotech Small-Cap Approvals — May 26, 2026
Biotech Small-Cap Approvals